{"hands_on_practices": [{"introduction": "In clinical microbiology, accurately classifying a pathogen's response to an antibiotic is crucial for effective treatment. This practice challenges you to act as a diagnostician, integrating multiple lines of experimental evidence—including the Minimum Inhibitory Concentration (MIC), killing kinetics, and population analysis—to distinguish between the related but distinct phenotypes of resistance, tolerance, and persistence [@problem_id:4661178]. Mastering this skill is key to moving beyond simple susceptibility testing and understanding the complex ways bacteria evade antibiotic killing.", "problem": "A clinical isolate of a Gram-negative pathogen is exposed to a bactericidal antibiotic in standardized assays. Broth microdilution shows that the minimum inhibitory concentration (MIC) is unchanged relative to its ancestor at $0.25\\,\\mu\\mathrm{g/mL}$, confirmed across $n=3$ independent experiments. In time–kill assays at $10\\times$ MIC, the minimum duration for killing $99\\%$ of the population (MDK99) increases from $30\\,\\mathrm{min}$ in the ancestor to $300\\,\\mathrm{min}$ in the isolate, with no evidence of biphasic killing over the first $4$ logs of decline. When survivors are washed, regrown without antibiotic, and retested, their MIC remains $0.25\\,\\mu\\mathrm{g/mL}$. Population analysis profiling shows no subpopulation able to grow above $2\\times$ MIC. Based only on fundamental definitions and standard pharmacodynamic reasoning, which interpretation best classifies and explains this phenotype?\n\nA. Antibiotic tolerance: the isolate is killed more slowly at supra-MIC concentrations, reflected by an increased MDK99, without a shift in MIC, indicating a reduced killing rate rather than reduced growth inhibition.\n\nB. Antibiotic resistance: the increased MDK99 indicates reduced drug efficacy consistent with a heritable increase in target insensitivity, so the MIC must be functionally elevated even if the measured MIC appears unchanged.\n\nC. Bacterial persistence: the unchanged MIC and survival over prolonged exposure indicate a small dormant subpopulation; the increased MDK99 is best explained by a persister tail.\n\nD. Heteroresistance: a minority subclone with a higher MIC causes prolonged survival at high drug concentrations while the bulk MIC remains unchanged, explaining the MDK99 increase.", "solution": "The problem statement will first be validated for scientific soundness, consistency, and completeness before a solution is attempted.\n\n### Step 1: Extract Givens\n-   **Organism:** A clinical isolate of a Gram-negative pathogen and its ancestor.\n-   **Antibiotic:** A bactericidal antibiotic.\n-   **Minimum Inhibitory Concentration (MIC):** The MIC of the isolate is unchanged relative to its ancestor. The value is $0.25\\,\\mu\\mathrm{g/mL}$, confirmed by $n=3$ independent experiments.\n-   **Time–Kill Assay Conditions:** Performed at a concentration of $10\\times$ MIC.\n-   **Minimum Duration for Killing 99% (MDK99):**\n    -   Ancestor: $30\\,\\mathrm{min}$.\n    -   Isolate: $300\\,\\mathrm{min}$.\n-   **Killing Kinetics:** There is no evidence of biphasic killing over the first $4$ logs of bacterial population decline.\n-   **Survivor Analysis:** Survivors from the time-kill assay, after being washed and regrown in antibiotic-free medium, exhibit an MIC of $0.25\\,\\mu\\mathrm{g/mL}$.\n-   **Population Analysis Profiling (PAP):** No subpopulation is detected that is able to grow at antibiotic concentrations above $2\\times$ MIC.\n-   **Task:** Classify and explain the phenotype based on fundamental definitions and standard pharmacodynamic reasoning.\n\n### Step 2: Validate Using Extracted Givens\nThe problem describes a series of standard microbiological experiments designed to characterize an antibiotic response phenotype.\n-   **Scientifically Grounded:** The concepts presented—MIC, time-kill assays, MDK99, persistence, tolerance, resistance, and heteroresistance—are all standard and fundamental principles in medical microbiology and pharmacology. The experimental data (e.g., MIC value, MDK values) are plausible.\n-   **Well-Posed:** The problem is well-posed. It provides a comprehensive set of experimental results that are designed to distinguish between several related but distinct phenotypes. The question asks for the best interpretation based on this specific evidence.\n-   **Objective:** The language is technical, precise, and quantitative, free of any subjective or ambiguous terminology.\n-   **Consistency and Completeness:** The provided data are internally consistent and sufficient to arrive at a definitive conclusion.\n    -   The unchanged MIC ($0.25\\,\\mu\\mathrm{g/mL}$) establishes that the concentration required to inhibit growth has not increased.\n    -   The increased MDK99 (from $30\\,\\mathrm{min}$ to $300\\,\\mathrm{min}$) demonstrates that the rate of killing at a supra-MIC concentration has significantly decreased.\n    -   The unchanged MIC of survivors after regrowth confirms that the phenotype is not due to the selection of stable, genetically resistant mutants.\n    -   The absence of biphasic killing specifically argues against the classical definition of persistence.\n    -   The PAP result specifically argues against heteroresistance.\n-   **Conclusion of Validation:** The problem statement is valid, scientifically sound, and provides a clear, consistent set of data for analysis.\n\n### Solution Derivation\nThe task is to differentiate between antibiotic resistance, tolerance, persistence, and heteroresistance using the provided experimental data. Let us analyze the data in light of the standard definitions of these phenotypes.\n\n1.  **Resistance vs. Susceptibility:** Antibiotic resistance is formally defined as an increase in the Minimum Inhibitory Concentration (MIC) of an organism to a particular antibiotic. The problem explicitly states that the MIC is unchanged at $0.25\\,\\mu\\mathrm{g/mL}$ compared to the ancestor. This directly contradicts the definition of resistance. Furthermore, when survivors of the antibiotic exposure are regrown, their MIC remains $0.25\\,\\mu\\mathrm{g/mL}$, confirming that no stable, heritable resistance has been selected. Therefore, the isolate is not resistant.\n\n2.  **Persistence vs. Tolerance:** Both persistence and tolerance describe scenarios where bacteria survive lethal antibiotic concentrations without an increase in MIC. The distinction lies in the mechanism and the population dynamics.\n    -   **Persistence** is characterized by the presence of a small, pre-existing subpopulation of dormant or slow-growing cells (persisters) that are phenotypically non-susceptible to the antibiotic. This results in a biphasic killing curve: an initial rapid decline of the susceptible majority followed by a much slower decline (a \"persister tail\") of the persister subpopulation. The problem states there is \"no evidence of biphasic killing over the first $4$ logs of decline,\" which is a substantial portion of the population. This monophasic, albeit slow, killing kinetic is inconsistent with the classic model of persistence.\n    -   **Tolerance** is defined as the ability of the *entire* bacterial population to survive a transient exposure to a bactericidal antibiotic, characterized by a reduced rate of killing without a change in the MIC. This phenotype is measured by an increase in the time required to kill the population (e.g., MDK99). The data show a tenfold increase in MDK99 (from $30\\,\\mathrm{min}$ to $300\\,\\mathrm{min}$) while the MIC remains constant. This perfectly aligns with the definition of tolerance. The entire population is less susceptible to killing, leading to a slower, monophasic death curve.\n\n3.  **Heteroresistance:** This phenotype is defined by the presence of a small subpopulation of cells that exhibit a higher MIC than the main population. This resistant subpopulation can be detected by Population Analysis Profiling (PAP), which involves plating a large inoculum on a range of antibiotic concentrations. The problem states that PAP \"shows no subpopulation able to grow above $2\\times$ MIC.\" This experimental result definitively rules out heteroresistance as the explanation for the observed phenotype.\n\n**Conclusion:** The combination of an unchanged MIC, a significantly increased MDK99, the lack of stable resistance in survivors, monophasic killing kinetics, and a negative PAP result points unequivocally to the phenotype being antibiotic tolerance.\n\n### Option-by-Option Analysis\n\n**A. Antibiotic tolerance: the isolate is killed more slowly at supra-MIC concentrations, reflected by an increased MDK99, without a shift in MIC, indicating a reduced killing rate rather than reduced growth inhibition.**\nThis statement is a precise and accurate description of antibiotic tolerance and is fully supported by all the data provided. The increased MDK99 quantifies the slower killing, the MIC is explicitly stated as unchanged, and the distinction between killing rate (pharmacodynamics) and growth inhibition (MIC) is the core of the tolerance definition.\n**Verdict: Correct.**\n\n**B. Antibiotic resistance: the increased MDK99 indicates reduced drug efficacy consistent with a heritable increase in target insensitivity, so the MIC must be functionally elevated even if the measured MIC appears unchanged.**\nThis statement is incorrect. It misclassifies the phenotype as resistance. The primary definition of resistance is an increased MIC, which is not observed. The claim that the MIC is \"functionally elevated\" despite direct measurement is an ad-hoc argument that contradicts standard definitions. The fact that survivors regrow with the original low MIC also refutes the idea of a heritable change characteristic of resistance.\n**Verdict: Incorrect.**\n\n**C. Bacterial persistence: the unchanged MIC and survival over prolonged exposure indicate a small dormant subpopulation; the increased MDK99 is best explained by a persister tail.**\nThis statement is incorrect. While persistence involves survival without an MIC change, it is characterized by biphasic killing kinetics (a \"persister tail\"). The problem explicitly states there is \"no evidence of biphasic killing.\" Therefore, the observed increase in MDK99 is due to a slow killing rate of the entire population, not the survival of a small persister subpopulation.\n**Verdict: Incorrect.**\n\n**D. Heteroresistance: a minority subclone with a higher MIC causes prolonged survival at high drug concentrations while the bulk MIC remains unchanged, explaining the MDK99 increase.**\nThis statement is incorrect. Heteroresistance is defined by the existence of a subpopulation with a higher MIC. The problem provides direct experimental evidence to refute this: \"Population analysis profiling shows no subpopulation able to grow above $2\\times$ MIC.\" This negative PAP result rules out heteroresistance.\n**Verdict: Incorrect.**\n\nThe only option that aligns with all provided experimental data and standard microbiological definitions is A. The isolate exhibits antibiotic tolerance.", "answer": "$$\\boxed{A}$$", "id": "4661178"}, {"introduction": "Heteroresistance, the presence of a resistant subpopulation within a seemingly susceptible bacterial culture, is a significant clinical challenge that can be missed by standard tests. This practice provides a hands-on approach to understanding this phenomenon by using data from a Population Analysis Profile (PAP), the gold standard for its detection [@problem_id:4661138]. You will perform a fundamental calculation to determine the precise frequency of the resistant subpopulation, transforming an abstract concept into a tangible quantitative measure.", "problem": "A clinical isolate is evaluated for antibiotic response using a Population Analysis Profile (PAP), defined as the relationship between viable colony-forming units per milliliter (CFU/mL) and antibiotic concentration. A PAP is constructed by plating a standardized inoculum across a series of antibiotic concentrations and counting colonies after incubation, where surviving colonies at high concentrations indicate subpopulations capable of replicative growth under drug exposure. Colony-forming unit (CFU) counts across antibiotic concentrations are given as follows (all CFU counts are per milliliter): at $0\\,\\mu\\text{g/mL}$, $2.5\\times 10^{9}$; at $1\\,\\mu\\text{g/mL}$, $1.8\\times 10^{9}$; at $2\\,\\mu\\text{g/mL}$, $6.0\\times 10^{7}$; at $4\\,\\mu\\text{g/mL}$, $3.1\\times 10^{5}$; and at $8\\,\\mu\\text{g/mL}$, $2.5\\times 10^{4}$. Using the fundamental definition that the frequency of survivors at a given concentration is the ratio of survivors at that concentration to the baseline inoculum without antibiotic, compute the survivor frequency at $8\\,\\mu\\text{g/mL}$. Express the final survivor frequency as a unitless decimal in standard scientific notation and round your answer to three significant figures. Do not include any units in your final numerical answer.", "solution": "The problem is first subjected to validation to ensure its scientific soundness, objectivity, and completeness.\n\n**Step 1: Extract Givens**\n- A Population Analysis Profile (PAP) is defined as the relationship between viable colony-forming units per milliliter (CFU/mL) and antibiotic concentration.\n- The baseline inoculum (CFU/mL at $0\\,\\mu\\text{g/mL}$) is $2.5\\times 10^{9}$.\n- The CFU count at $1\\,\\mu\\text{g/mL}$ is $1.8\\times 10^{9}$.\n- The CFU count at $2\\,\\mu\\text{g/mL}$ is $6.0\\times 10^{7}$.\n- The CFU count at $4\\,\\mu\\text{g/mL}$ is $3.1\\times 10^{5}$.\n- The CFU count at $8\\,\\mu\\text{g/mL}$ is $2.5\\times 10^{4}$.\n- The frequency of survivors at a given concentration is defined as the ratio of survivors at that concentration to the baseline inoculum without antibiotic.\n- The task is to compute the survivor frequency at $8\\,\\mu\\text{g/mL}$.\n- The final answer must be a unitless decimal in standard scientific notation, rounded to three significant figures.\n\n**Step 2: Validate Using Extracted Givens**\nThe problem is evaluated against the validation criteria.\n- **Scientifically Grounded**: The problem is scientifically sound. Population Analysis Profiling is a standard and well-established technique in microbiology for characterizing antibiotic resistance, particularly heteroresistance. The provided CFU values are realistic for a dense bacterial culture and its response to increasing antibiotic concentrations. The definition of survivor frequency is standard practice in this context.\n- **Well-Posed**: The problem is well-posed. It provides all necessary data points and a clear, unambiguous definition to perform the required calculation. A unique solution exists.\n- **Objective**: The problem is stated objectively, using precise scientific terminology and quantitative data. It is free from subjective or biased language.\n- **Conclusion**: The problem does not violate any of the invalidity criteria. It is a valid, solvable scientific problem.\n\n**Step 3: Verdict and Action**\nThe problem is deemed valid. A complete solution will now be provided.\n\nThe problem requires the calculation of the survivor frequency at a specific antibiotic concentration. The fundamental definition of survivor frequency is provided in the problem statement. Let $N(c)$ represent the number of colony-forming units per milliliter (CFU/mL) that survive at an antibiotic concentration $c$. The baseline inoculum, which corresponds to the total viable population before selection pressure is applied, is the CFU count at zero antibiotic concentration, denoted as $N(0)$.\n\nThe problem provides the following data:\n- Baseline inoculum: $N(0) = 2.5 \\times 10^{9} \\text{ CFU/mL}$\n- Survivors at $8\\,\\mu\\text{g/mL}$: $N(8) = 2.5 \\times 10^{4} \\text{ CFU/mL}$\n\nThe frequency of survivors, $F(c)$, at a concentration $c$ is defined as the ratio of the number of surviving cells at that concentration to the number of cells in the baseline inoculum. This can be expressed mathematically as:\n$$F(c) = \\frac{N(c)}{N(0)}$$\nWe are asked to compute the survivor frequency at the antibiotic concentration of $c = 8\\,\\mu\\text{g/mL}$. Substituting the given values into the formula for $F(8)$:\n$$F(8) = \\frac{N(8)}{N(0)} = \\frac{2.5 \\times 10^{4}}{2.5 \\times 10^{9}}$$\nThe calculation proceeds by dividing the numerical coefficients and subtracting the exponents of $10$:\n$$F(8) = \\left(\\frac{2.5}{2.5}\\right) \\times 10^{4-9}$$\n$$F(8) = 1 \\times 10^{-5}$$\nThe problem specifies that the final answer should be expressed in standard scientific notation and rounded to three significant figures. To express the number $1$ with three significant figures, we write it as $1.00$. Therefore, the survivor frequency is:\n$$F(8) = 1.00 \\times 10^{-5}$$\nThis is a unitless quantity, as it is a ratio of two quantities with the same units (CFU/mL).", "answer": "$$\\boxed{1.00 \\times 10^{-5}}$$", "id": "4661138"}, {"introduction": "Unlike resistance, which is defined by an increased ability to grow in the presence of a drug, tolerance is defined by a decreased rate of killing. This exercise focuses on quantifying tolerance by analyzing time-kill curve data, a cornerstone of pharmacodynamic studies [@problem_id:4661159]. You will learn to calculate the Minimum Duration for Killing 99% (MDK99), a key metric that captures how physiological states like nutrient starvation can dramatically prolong bacterial survival during antibiotic therapy.", "problem": "A clonal bacterial population is exposed to a fixed concentration of a bactericidal antibiotic well above the minimum inhibitory concentration (MIC). Viable counts are measured as colony-forming units (CFU) per milliliter at specified times. For each condition, assume that between the listed time points the viable count decays exponentially with time (equivalently, the base-$10$ logarithm of the CFU is a linear function of time within each interval). Define the survival fraction as $S(t) = \\frac{N(t)}{N(0)}$, where $N(t)$ is the CFU at time $t$ and $N(0)$ is the initial inoculum. The minimum duration for killing $99\\%$ (MDK99) is defined as the earliest time $t$ such that $S(t) = 0.01$. In other words, MDK99 is the earliest time the CFU decreases to $0.01 \\times N(0)$.\n\nTwo conditions are measured for the same strain with the same initial inoculum:\n\n- Control condition (nutrient-replete, no tolerance-inducing pretreatment):\n  - Time (hours) and CFU (per milliliter):\n    - $t = 0$: $N(t) = 1.0 \\times 10^{8}$\n    - $t = 0.25$: $N(t) = 1.778 \\times 10^{7}$\n    - $t = 0.50$: $N(t) = 3.162 \\times 10^{6}$\n    - $t = 0.75$: $N(t) = 5.623 \\times 10^{5}$\n    - $t = 1.00$: $N(t) = 1.000 \\times 10^{5}$\n    - $t = 1.50$: $N(t) = 7.079 \\times 10^{4}$\n    - $t = 2.00$: $N(t) = 5.012 \\times 10^{4}$\n\n- Tolerance-inducing condition (prior nutrient starvation for $18$ hours before antibiotic exposure):\n  - Time (hours) and CFU (per milliliter):\n    - $t = 0$: $N(t) = 1.0 \\times 10^{8}$\n    - $t = 0.50$: $N(t) = 2.512 \\times 10^{7}$\n    - $t = 1.00$: $N(t) = 6.309 \\times 10^{6}$\n    - $t = 1.50$: $N(t) = 1.585 \\times 10^{6}$\n    - $t = 2.00$: $N(t) = 3.981 \\times 10^{5}$\n    - $t = 3.00$: $N(t) = 2.512 \\times 10^{5}$\n\nTasks:\n- Using the definition $S(t) = \\frac{N(t)}{N(0)}$, determine the MDK99 (in hours) for each condition as the earliest time when $N(t)$ reaches $0.01 \\times N(0)$. Use the stated exponential-within-intervals assumption to estimate MDK99 by interpolation.\n- Compute the fold-change $F$ in MDK99 under tolerance relative to control, defined as $F = \\frac{\\text{MDK}99_{\\text{tolerance}}}{\\text{MDK}99_{\\text{control}}}$.\n\nReport only the final fold-change $F$ as a dimensionless number, rounded to three significant figures.", "solution": "The problem statement is critically validated before proceeding to a solution.\n\n### Step 1: Extract Givens\n- **Model Assumption:** The viable count $N(t)$ decays exponentially with time $t$ between listed time points. This is equivalent to stating that $y(t) = \\log_{10}(N(t))$ is a linear function of time $t$ within each interval.\n- **Definition of Survival Fraction:** $S(t) = \\frac{N(t)}{N(0)}$.\n- **Definition of MDK99:** The minimum duration for killing $99\\%$, defined as the earliest time $t$ at which $S(t) = 0.01$. This is equivalent to finding the time $t$ where $N(t) = 0.01 \\times N(0)$.\n- **Initial Condition (Both Cases):** $N(0) = 1.0 \\times 10^{8}$ CFU/mL.\n- **Control Condition Data:**\n  - $(t \\text{ [h]}, N(t) \\text{ [CFU/mL]}): (0, 1.0 \\times 10^{8}), (0.25, 1.778 \\times 10^{7}), (0.50, 3.162 \\times 10^{6}), (0.75, 5.623 \\times 10^{5}), (1.00, 1.000 \\times 10^{5}), (1.50, 7.079 \\times 10^{4}), (2.00, 5.012 \\times 10^{4})$.\n- **Tolerance-inducing Condition Data:**\n  - $(t \\text{ [h]}, N(t) \\text{ [CFU/mL]}): (0, 1.0 \\times 10^{8}), (0.50, 2.512 \\times 10^{7}), (1.00, 6.309 \\times 10^{6}), (1.50, 1.585 \\times 10^{6}), (2.00, 3.981 \\times 10^{5}), (3.00, 2.512 \\times 10^{5})$.\n- **Task 1:** Determine MDK99 for each condition by interpolation.\n- **Task 2:** Compute the fold-change $F = \\frac{\\text{MDK}99_{\\text{tolerance}}}{\\text{MDK}99_{\\text{control}}}$.\n- **Final Answer Format:** Report $F$ rounded to three significant figures.\n\n### Step 2: Validate Using Extracted Givens\nThe problem is scientifically grounded, describing a standard time-kill curve experiment in microbiology. The concepts used (MDK99, CFU, antibiotic tolerance) are standard in the field. The provided data, while idealized to exhibit perfect piecewise linearity on a semi-log plot, is internally consistent and within a plausible range for such experiments. The problem is well-posed, objective, and contains all necessary information to arrive at a unique, meaningful solution through the specified method of interpolation. No scientific principles are violated.\n\n### Step 3: Verdict and Action\nThe problem is deemed **valid**. A full solution will be provided.\n\n### Solution\n\nThe primary objective is to calculate the fold-change $F$ in the MDK99 value between two conditions. The MDK99 is the time required for the bacterial population $N(t)$ to drop to $1\\%$ of its initial value $N(0)$.\n\nGiven the initial population $N(0) = 1.0 \\times 10^{8}$ CFU/mL, the target population for MDK99, denoted $N_{\\text{target}}$, is:\n$$N_{\\text{target}} = 0.01 \\times N(0) = 0.01 \\times (1.0 \\times 10^{8}) = 1.0 \\times 10^{6} \\text{ CFU/mL}$$\n\nThe problem states that the base-$10$ logarithm of the population, $y(t) = \\log_{10}(N(t))$, is a linear function of time $t$ between the given data points. We will therefore work with the log-transformed data. The target population in log scale is:\n$$y_{\\text{target}} = \\log_{10}(N_{\\text{target}}) = \\log_{10}(1.0 \\times 10^{6}) = 6$$\n\nWe must find the time $t$ at which $y(t) = 6$ for each condition by using linear interpolation.\n\n**1. MDK99 for the Control Condition ($t_{\\text{control}}$)**\n\nFirst, we transform the control data into log-scale pairs $(t, y(t))$:\n- $t = 0.50$, $N = 3.162 \\times 10^{6} \\implies y = \\log_{10}(3.162 \\times 10^{6}) \\approx 6.5$\n- $t = 0.75$, $N = 5.623 \\times 10^{5} \\implies y = \\log_{10}(5.623 \\times 10^{5}) \\approx 5.75$\n\nThe target value $y_{\\text{target}} = 6$ lies between $y=6.5$ at $t_1 = 0.50$ hours and $y=5.75$ at $t_2 = 0.75$ hours. We perform linear interpolation between the points $(t_1, y_1) = (0.50, 6.5)$ and $(t_2, y_2) = (0.75, 5.75)$.\n\nThe formula for linear interpolation to find the time $t_{\\text{control}}$ corresponding to $y_{\\text{target}}$ is:\n$$t_{\\text{control}} = t_1 + (t_2 - t_1) \\frac{y_{\\text{target}} - y_1}{y_2 - y_1}$$\nSubstituting the values:\n$$t_{\\text{control}} = 0.50 + (0.75 - 0.50) \\frac{6 - 6.5}{5.75 - 6.5}$$\n$$t_{\\text{control}} = 0.50 + (0.25) \\frac{-0.5}{-0.75}$$\n$$t_{\\text{control}} = 0.50 + (0.25) \\frac{2}{3} = \\frac{1}{2} + \\frac{1}{4} \\cdot \\frac{2}{3} = \\frac{1}{2} + \\frac{2}{12} = \\frac{1}{2} + \\frac{1}{6}$$\n$$t_{\\text{control}} = \\frac{3}{6} + \\frac{1}{6} = \\frac{4}{6} = \\frac{2}{3} \\text{ hours}$$\n\n**2. MDK99 for the Tolerance-inducing Condition ($t_{\\text{tolerance}}$)**\n\nNext, we transform the tolerance condition data into log-scale pairs $(t, y(t))$:\n- $t = 1.50$, $N = 1.585 \\times 10^{6} \\implies y = \\log_{10}(1.585 \\times 10^{6}) \\approx 6.2$\n- $t = 2.00$, $N = 3.981 \\times 10^{5} \\implies y = \\log_{10}(3.981 \\times 10^{5}) \\approx 5.6$\n\nThe target value $y_{\\text{target}} = 6$ lies between $y=6.2$ at $t_1' = 1.50$ hours and $y=5.6$ at $t_2' = 2.00$ hours. We interpolate between the points $(t_1', y_1') = (1.50, 6.2)$ and $(t_2', y_2') = (2.00, 5.6)$.\n\nUsing the same interpolation formula:\n$$t_{\\text{tolerance}} = t_1' + (t_2' - t_1') \\frac{y_{\\text{target}} - y_1'}{y_2' - y_1'}$$\nSubstituting the values:\n$$t_{\\text{tolerance}} = 1.50 + (2.00 - 1.50) \\frac{6 - 6.2}{5.6 - 6.2}$$\n$$t_{\\text{tolerance}} = 1.50 + (0.50) \\frac{-0.2}{-0.6}$$\n$$t_{\\text{tolerance}} = 1.50 + (0.50) \\frac{1}{3} = \\frac{3}{2} + \\frac{1}{2} \\cdot \\frac{1}{3} = \\frac{3}{2} + \\frac{1}{6}$$\n$$t_{\\text{tolerance}} = \\frac{9}{6} + \\frac{1}{6} = \\frac{10}{6} = \\frac{5}{3} \\text{ hours}$$\n\n**3. Compute the Fold-Change $F$**\n\nThe fold-change $F$ is the ratio of the two MDK99 values:\n$$F = \\frac{\\text{MDK}99_{\\text{tolerance}}}{\\text{MDK}99_{\\text{control}}} = \\frac{t_{\\text{tolerance}}}{t_{\\text{control}}}$$\n$$F = \\frac{5/3}{2/3} = \\frac{5}{3} \\cdot \\frac{3}{2} = \\frac{5}{2} = 2.5$$\n\nThe problem requires the final answer to be rounded to three significant figures.\n$$F = 2.50$$\nThis result indicates that the tolerance-inducing pretreatment increased the time required to kill $99\\%$ of the bacterial population by a factor of $2.5$.", "answer": "$$\\boxed{2.50}$$", "id": "4661159"}]}